262 related articles for article (PubMed ID: 32717920)
1. Investigation of Strand-Selective Interaction of SNA-Modified siRNA with AGO2-MID.
Kamiya Y; Takeyama Y; Mizuno T; Satoh F; Asanuma H
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32717920
[TBL] [Abstract][Full Text] [Related]
2. Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes.
Matranga C; Tomari Y; Shin C; Bartel DP; Zamore PD
Cell; 2005 Nov; 123(4):607-20. PubMed ID: 16271386
[TBL] [Abstract][Full Text] [Related]
3. Relative Quantification of siRNA Strand Loading into Ago2 for Design of Highly Active siRNAs.
Angart PA; Adu-Berchie K; Carlson RJ; Vocelle DB; Chan C; Walton SP
Methods Mol Biol; 2019; 1974():41-56. PubMed ID: 31098994
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of stability and activity of siRNA by terminal substitution with serinol nucleic acid (SNA).
Kamiya Y; Takai J; Ito H; Murayama K; Kashida H; Asanuma H
Chembiochem; 2014 Nov; 15(17):2549-55. PubMed ID: 25233814
[TBL] [Abstract][Full Text] [Related]
5. siRNA potency enhancement via chemical modifications of nucleotide bases at the 5'-end of the siRNA guide strand.
Shinohara F; Oashi T; Harumoto T; Nishikawa T; Takayama Y; Miyagi H; Takahashi Y; Nakajima T; Sawada T; Koda Y; Makino A; Sato A; Hamaguchi K; Suzuki M; Yamamoto J; Tomari Y; Saito JI
RNA; 2021 Feb; 27(2):163-173. PubMed ID: 33177188
[TBL] [Abstract][Full Text] [Related]
6. Induction of RNAi Responses by Short Left-Handed Hairpin RNAi Triggers.
Hagopian JC; Hamil AS; van den Berg A; Meade BR; Eguchi A; Palm-Apergi C; Dowdy SF
Nucleic Acid Ther; 2017 Oct; 27(5):260-271. PubMed ID: 28933656
[TBL] [Abstract][Full Text] [Related]
7. Effects of Chemical Modifications on siRNA Strand Selection in Mammalian Cells.
Varley AJ; Hammill ML; Salim L; Desaulniers JP
Nucleic Acid Ther; 2020 Aug; 30(4):229-236. PubMed ID: 32175808
[TBL] [Abstract][Full Text] [Related]
8. Terminal Duplex Stability and Nucleotide Identity Differentially Control siRNA Loading and Activity in RNA Interference.
Angart PA; Carlson RJ; Adu-Berchie K; Walton SP
Nucleic Acid Ther; 2016 Oct; 26(5):309-317. PubMed ID: 27399870
[TBL] [Abstract][Full Text] [Related]
9. Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation.
Rand TA; Petersen S; Du F; Wang X
Cell; 2005 Nov; 123(4):621-9. PubMed ID: 16271385
[TBL] [Abstract][Full Text] [Related]
10. Conversion of pre-RISC to holo-RISC by Ago2 during assembly of RNAi complexes.
Kim K; Lee YS; Carthew RW
RNA; 2007 Jan; 13(1):22-9. PubMed ID: 17123955
[TBL] [Abstract][Full Text] [Related]
11. Re-Engineering RNA Molecules into Therapeutic Agents.
Egli M; Manoharan M
Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
[TBL] [Abstract][Full Text] [Related]
12. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic analysis of the enhanced RNAi activity by 6-mCEPh-purine at the 5' end of the siRNA guide strand.
Brechin V; Shinohara F; Saito JI; Seitz H; Tomari Y
RNA; 2021 Feb; 27(2):151-162. PubMed ID: 33177187
[TBL] [Abstract][Full Text] [Related]
14. Structurally modulated codelivery of siRNA and Argonaute 2 for enhanced RNA interference.
Li J; Wu C; Wang W; He Y; Elkayam E; Joshua-Tor L; Hammond PT
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2696-E2705. PubMed ID: 29432194
[TBL] [Abstract][Full Text] [Related]
15. Slicer function of Drosophila Argonautes and its involvement in RISC formation.
Miyoshi K; Tsukumo H; Nagami T; Siomi H; Siomi MC
Genes Dev; 2005 Dec; 19(23):2837-48. PubMed ID: 16287716
[TBL] [Abstract][Full Text] [Related]
16. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
Yoo JW; Kim S; Lee DK
Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure, stability and in vitro RNAi activity of oligoribonucleotides containing the ribo-difluorotoluyl nucleotide: insights into substrate requirements by the human RISC Ago2 enzyme.
Li F; Pallan PS; Maier MA; Rajeev KG; Mathieu SL; Kreutz C; Fan Y; Sanghvi J; Micura R; Rozners E; Manoharan M; Egli M
Nucleic Acids Res; 2007; 35(19):6424-38. PubMed ID: 17881374
[TBL] [Abstract][Full Text] [Related]
18. Elimination of Off-Target Effect by Chemical Modification of 5'-End of siRNA.
Shiohama Y; Fujita R; Sonokawa M; Hisano M; Kotake Y; Krstic-Demonacos M; Demonacos C; Kashiwazaki G; Kitayama T; Fujii M
Nucleic Acid Ther; 2022 Oct; 32(5):438-447. PubMed ID: 35404139
[TBL] [Abstract][Full Text] [Related]
19. Potent RNAi by short RNA triggers.
Chu CY; Rana TM
RNA; 2008 Sep; 14(9):1714-9. PubMed ID: 18658119
[TBL] [Abstract][Full Text] [Related]
20. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.
Gregory RI; Chendrimada TP; Cooch N; Shiekhattar R
Cell; 2005 Nov; 123(4):631-40. PubMed ID: 16271387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
